Incyte officer Steven Stein proposes $28.3M sale
The shares are described as acquired from the issuer by stock-option exercise for cash, with Morgan Stanley Smith Barney LLC listed as broker.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Steven Stein, an officer of Incyte Corp., filed a notice of a proposed sale of 240,193 common shares, with an aggregate market value of $28,345,175.93 and an approximate sale date of November 6, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice describes the shares as acquired from the issuer through exercise of stock options for cash.
Key Figures
Key Terms
Rule 144 regulatory
Exercise of Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.